Tadakazu Hisamatsu Selected Research

Tadakazu Hisamatsu Research Topics

Disease

49	Ulcerative Colitis 11/2022 - 05/2005
36	Crohn Disease (Crohn's Disease) 11/2022 - 04/2003
28	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 05/2005
25	Colitis 05/2021 - 05/2005
17	Inflammation (Inflammations) 01/2021 - 08/2003
14	Infections 06/2021 - 02/2007
6	Necrosis 05/2022 - 06/2012
5	Abdominal Pain (Pain, Abdominal) 01/2022 - 01/2015
5	Neoplasms (Cancer) 01/2021 - 07/2016
4	Tuberculosis (Tuberculoses) 01/2018 - 01/2018
3	COVID-19 09/2022 - 01/2021
3	Hemorrhage 01/2022 - 01/2010
3	Body Weight (Weight, Body) 02/2020 - 04/2006
3	Ulcer 01/2020 - 11/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 01/2022
2	Anemia 09/2022 - 01/2020
2	Sepsis (Septicemia) 08/2022 - 09/2012
2	Chronic Disease (Chronic Diseases) 06/2022 - 06/2020
2	Herpes Zoster 03/2022 - 10/2019
2	Diarrhea 01/2022 - 06/2015
2	Hypersensitivity (Allergy) 01/2022 - 04/2018
2	Fever (Fevers) 01/2022 - 01/2015
2	Adenoma (Adenomas) 10/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 04/2018
2	Skin Neoplasms (Skin Cancer) 12/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 07/2020 - 01/2014
2	Rectal Neoplasms (Rectal Cancer) 05/2020 - 01/2019
2	Cholangitis 05/2020 - 10/2019
2	Hypoalbuminemia 01/2020 - 01/2007
2	Leukopenia 10/2019 - 09/2018
2	Abscess 11/2018 - 01/2014
2	Pathologic Constriction (Stenosis) 07/2018 - 01/2015
2	Celiac Disease (Celiac Sprue) 02/2018 - 07/2016
1	Arthritis (Polyarthritis) 10/2022
1	Hypoproteinemia 09/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 08/2022

Drug/Important Bio-Agent (IBA)

13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2008
11	Adalimumab (Humira)FDA Link 10/2021 - 01/2014
11	Infliximab (Remicade)FDA Link 03/2021 - 06/2009
11	CytokinesIBA 07/2018 - 08/2003
9	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 12/2012
7	Ustekinumab (CNTO 1275)FDA Link 08/2022 - 01/2019
7	Interleukin-23 (Interleukin 23)IBA 01/2022 - 11/2005
6	Biological ProductsIBA 11/2022 - 07/2019
6	SteroidsIBA 09/2022 - 01/2007
6	2-mercaptopurineIBA 12/2021 - 01/2015
6	Immunologic Factors (Immunomodulators)IBA 09/2020 - 03/2017
5	Monoclonal AntibodiesIBA 01/2020 - 10/2005
5	Interleukin-12 (IL 12)IBA 01/2020 - 11/2005
5	Dextran SulfateIBA 01/2019 - 04/2006
5	AntigensIBA 03/2017 - 10/2005
4	AntibodiesIBA 05/2022 - 09/2020
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
4	InterleukinsIBA 01/2022 - 02/2009
4	Proteins (Proteins, Gene)FDA Link 10/2017 - 08/2003
4	RetinoidsIBA 10/2014 - 09/2011
3	tofacitinibIBA 10/2022 - 10/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 10/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
3	Immunoglobulin G (IgG)IBA 12/2021 - 01/2007
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2021 - 01/2020
3	LactoferrinIBA 05/2021 - 01/2020
3	Azathioprine (Imuran)FDA LinkGeneric 09/2019 - 11/2016
3	Biosimilar PharmaceuticalsIBA 08/2019 - 11/2018
3	EnzymesIBA 09/2018 - 04/2006
3	Interleukin-10 (Interleukin 10)IBA 06/2013 - 03/2010
3	Therapeutic UsesIBA 11/2008 - 05/2005
3	Messenger RNA (mRNA)IBA 11/2008 - 08/2003
2	Janus Kinase InhibitorsIBA 10/2022 - 10/2019
2	Immunoglobulin A (IgA)IBA 05/2022 - 01/2010
2	risankizumabIBA 01/2022 - 01/2022
2	vedolizumabIBA 12/2021 - 09/2021
2	fosfestrol (Kyorin)FDA Link 09/2021 - 08/2019
2	DiamondIBA 09/2020 - 09/2019
2	TabletsIBA 07/2020 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 06/2020 - 05/2005
2	Indigo Carmine (Indigo Blue)IBA 02/2020 - 01/2018
2	C-Reactive ProteinIBA 01/2020 - 01/2007
2	Histidine (L-Histidine)FDA Link 01/2015 - 02/2009
2	Prednisolone (Predate)FDA LinkGeneric 01/2015 - 12/2012
2	Capsules (Microcapsules)IBA 09/2014 - 07/2013
2	Bacterial AntigensIBA 05/2013 - 06/2012
2	InterferonsIBA 05/2013 - 11/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2013 - 03/2010
2	Amino Acids FDA Link 01/2012 - 02/2009
2	Dextrans (Dextran)FDA Link 10/2009 - 05/2005
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2009 - 05/2005
1	AdrenomedullinIBA 11/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2022
1	Organic Anion TransportersIBA 09/2022
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2022

Therapy/Procedure

37	Therapeutics 03/2022 - 05/2005
4	Colectomy 07/2020 - 11/2010
2	Oral Administration 05/2022 - 12/2013
2	Biological Therapy 01/2022 - 01/2021
2	Punctures 01/2021 - 09/2012
2	Drug Therapy (Chemotherapy) 05/2020 - 11/2006
2	Remission Induction 12/2013 - 03/2013